Published online before print September 13, 2001, doi: 10.1161/hh1901.097083
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
© 2001 American Heart Association, Inc.
Molecular Medicine |
Constitutive and Inducible Expression of Cyp1a1 and Cyp1b1 in Vascular Smooth Muscle Cells
Role of the Ahr bHLH/PAS Transcription Factor
From the Center for Environmental and Rural Health, Texas A&M University, College Station, Tex.
Correspondence to Dr Kenneth S. Ramos, Center for Environmental and Rural Health, Texas A&M University, College Station, TX 77843-4455. E-mail kramos{at}cvm.tamu.edu
Abstract — Ahr is a ligand-activated bHLH/PAS transcription factor involved in cytochrome P450 (CYP) gene regulation and murine susceptibility to atherogenic stimuli. The present studies were conducted to examine constitutive and inducible expression of Cyp1a1 and Cyp1b1 in vascular smooth muscle cells (VSMCs) from Ahr+/+ and Ahr-/- mice. Cyp1a1 mRNA was not expressed constitutively in VSMCs irrespective of Ahr phenotype. Although Cyp1a1 was inducible in Ahr+/+ by 3 µmol/L benzo(a)pyrene, a known hydrocarbon inducer, the protein was uninducible. In contrast, Cyp1b1 mRNA and protein were expressed under constitutive and inducible conditions irrespective of Ahr phenotype or growth status. CYP-encoded aryl hydrocarbon hydroxylase activity was higher in Ahr-/- VSMCs under constitutive conditions and induced by benzo(a)pyrene in Ahr+/+ and Ahr-/- VSMCs. CYP expression was influenced by mitogenic status, because randomly cycling cells consistently exhibited higher levels than growth-arrested counterparts. Actinomycin D (2 µg/mL) or cycloheximide (10 µmol/L) did not inhibit constitutive or hydrocarbon-inducible aryl hydrocarbon hydroxylase activity in VSMCs. These data indicate that in murine VSMCs, expression of Cyp1al and Cyp1b1 is differentially influenced by Ahr phenotype and mitogenic status, with patterns that may dictate inherent susceptibility to atherogenic stimuli.
Key Words: Cyp1a1 • Cyp1b1 • vascular smooth muscle cells • aryl hydrocarbon receptor • atherogenesis
This article has been cited by other articles:
 |
|
 |
|
  M. A. Nayeem, D. S. Ponnoth, M. A. Boegehold, D. C. Zeldin, J. R. Falck, and S. J. Mustafa High-salt diet enhances mouse aortic relaxation through adenosine A2A receptor via CYP epoxygenases Am J Physiol Regulatory Integrative Comp Physiol, March 1, 2009; 296(3): R567 - R574. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. E. Conway, Y. Sakurai, D. Weiss, J. D. Vega, W. R. Taylor, H. Jo, S. G. Eskin, C. B. Marcus, and L. V. McIntire Expression of CYP1A1 and CYP1B1 in human endothelial cells: regulation by fluid shear stress Cardiovasc Res, March 1, 2009; 81(4): 669 - 677. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Tang, E. A. Scheef, S. Wang, C. M. Sorenson, C. B. Marcus, C. R. Jefcoate, and N. Sheibani CYP1B1 expression promotes the proangiogenic phenotype of endothelium through decreased intracellular oxidative stress and thrombospondin-2 expression Blood, January 15, 2009; 113(3): 744 - 754. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. A. Nayeem, S. M. Poloyac, J. R. Falck, D. C. Zeldin, C. Ledent, D. S. Ponnoth, H. R. Ansari, and S. J. Mustafa Role of CYP epoxygenases in A2AAR-mediated relaxation using A2AAR-null and wild-type mice Am J Physiol Heart Circ Physiol, November 1, 2008; 295(5): H2068 - H2078. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H.-C. Yin, H.-P. Tseng, H.-Y. Chung, C.-Y. Ko, W.-S. Tzou, D. R. Buhler, and C.-H. Hu Influence of TCDD on Zebrafish CYP1B1 Transcription during Development Toxicol. Sci., May 1, 2008; 103(1): 158 - 168. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Aimova, L. Svobodova, V. Kotrbova, B. Mrazova, P. Hodek, J. Hudecek, R. Vaclavikova, E. Frei, and M. Stiborova The Anticancer Drug Ellipticine Is a Potent Inducer of Rat Cytochromes P450 1A1 and 1A2, Thereby Modulating Its Own Metabolism Drug Metab. Dispos., October 1, 2007; 35(10): 1926 - 1934. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. G. Shertzer, M. B. Genter, G. Talaska, C. P. Curran, D. W. Nebert, and T. P. Dalton 7H-dibenzo[c,g]carbazole metabolism by the mouse and human CYP1 family of enzymes Carcinogenesis, June 1, 2007; 28(6): 1371 - 1378. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. A. Tsuji and T. Walle Inhibition of benzo[a]pyrene-activating enzymes and DNA binding in human bronchial epithelial BEAS-2B cells by methoxylated flavonoids Carcinogenesis, August 1, 2006; 27(8): 1579 - 1585. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Anazawa, P. C. Dimayuga, H. Li, S. Tani, J. Bradfield, K.-Y. Chyu, S. Kaul, P. K. Shah, and B. Cercek Effect of Exposure to Cigarette Smoke on Carotid Artery Intimal Thickening: The Role of Inducible NO Synthase Arterioscler Thromb Vasc Biol, September 1, 2004; 24(9): 1652 - 1658. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. A. J. Godard, R. M. Smolowitz, J. Y. Wilson, R. S. Payne, and J. J. Stegeman Induction of Cetacean Cytochrome P4501A1 by {beta}-Naphthoflavone Exposure of Skin Biopsy Slices Toxicol. Sci., August 1, 2004; 80(2): 268 - 275. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Uno, T. P. Dalton, S. Derkenne, C. P. Curran, M. L. Miller, H. G. Shertzer, and D. W. Nebert Oral Exposure to Benzo[a]pyrene in the Mouse: Detoxication by Inducible Cytochrome P450 Is More Important Than Metabolic Activation Mol. Pharmacol., May 1, 2004; 65(5): 1225 - 1237. [Abstract] [Full Text]
|
|
|
|
 |
|
 P. Gibson, J. H. Gill, P. A. Khan, J. M. Seargent, S. W. Martin, P. A. Batman, J. Griffith, C. Bradley, J. A. Double, M. C. Bibby, et al. Cytochrome P450 1B1 (CYP1B1) Is Overexpressed in Human Colon Adenocarcinomas Relative to Normal Colon: Implications for Drug Development Mol. Cancer Ther., June 1, 2003; 2(6): 527 - 534. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. D. Johnson, Y. Balagurunathan, K. P. Lu, M. Tadesse, M. H. Falahatpisheh, R. J. Carroll, E. R. Dougherty, C. A. Afshari, and K. S. Ramos Genomic profiles and predictive biological networks in oxidant-induced atherogenesis Physiol Genomics, May 13, 2003; 13(3): 263 - 275. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. Moorthy, K. P. Miller, W. Jiang, E. S. Williams, S. R. Kondraganti, and K. S. Ramos Role of Cytochrome P4501B1 in Benzo[a]pyrene Bioactivation to DNA-Binding Metabolites in Mouse Vascular Smooth Muscle Cells: Evidence from 32P-Postlabeling for Formation of 3-Hydroxybenzo[a]pyrene and Benzo[a]pyrene-3,6-quinone as Major Proximate Genotoxic Intermediates J. Pharmacol. Exp. Ther., April 1, 2003; 305(1): 394 - 401. [Abstract] [Full Text]
|
|
|
|
|
|
L. Granberg, A. Ostergren, I. Brandt, and E. B. Brittebo CYP1A1 and CYP1B1 in Blood-Brain Interfaces: CYP1A1-Dependent Bioactivation of 7,12-Dimethylbenz(a)anthracene in Endothelial Cells Drug Metab. Dispos., March 1, 2003; 31(3): 259 - 265. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Moorthy, K. P. Miller, W. Jiang, and K. S. Ramos The atherogen 3-methylcholanthrene induces multiple DNA adducts in mouse aortic smooth muscle cells: role of cytochrome P4501B1 Cardiovasc Res, March 1, 2002; 53(4): 1002 - 1009. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. McNamara and G. A. FitzGerald Smoking-Induced Vascular Disease: A New Twist on an Old Theme Circ. Res., September 28, 2001; 89(7): 563 - 565. [Full Text] [PDF]
|
|